| A review of mathematical models for tumor dynamics and treatment resistance evolution of solid tumors A Yin, DJAR Moes, JGC van Hasselt, JJ Swen, HJ Guchelaar CPT: pharmacometrics & systems pharmacology 8 (10), 720-737, 2019 | 135 | 2019 |
| Population pharmacokinetics analysis of olanzapine for Chinese psychotic patients based on clinical therapeutic drug monitoring data with assistance of meta-analysis A Yin, D Shang, Y Wen, L Li, T Zhou, W Lu European journal of clinical pharmacology 72, 933-944, 2016 | 16 | 2016 |
| Pharmacokinetic-pharmacodynamic analysis of ciprofloxacin in elderly Chinese patients with lower respiratory tract infections caused by Gram-negative bacteria XY Gai, SN Bo, N Shen, QT Zhou, AY Yin, W Lu Chinese medical journal 132 (06), 638-646, 2019 | 15 | 2019 |
| Population pharmacokinetic and pharmacogenetic analysis of mitotane in patients with adrenocortical carcinoma: towards individualized dosing A Yin, MHT Ettaieb, JJ Swen, L van Deun, TMA Kerkhofs, ... Clinical pharmacokinetics 60, 89-102, 2021 | 8 | 2021 |
| Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstriction A Yin, A Yamada, WB Stam, JGC van Hasselt, PH van der Graaf British Journal of Pharmacology 175 (16), 3394-3406, 2018 | 7 | 2018 |
| Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance A Yin, JGC van Hasselt, HJ Guchelaar, LE Friberg, DJAR Moes Scientific Reports 12 (1), 4206, 2022 | 5 | 2022 |
| Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib A Yin, GDM Veerman, JGC van Hasselt, CMJ Steendam, HJ Dubbink, ... CPT: Pharmacometrics & Systems Pharmacology, 2024 | | 2024 |
| Computational modeling of pharmacokinetics and tumor dynamics to guide anti-cancer treatment A Yin Leiden University, 2024 | | 2024 |
